| Dr Paola M Seidel, MD | |
|
2615 W 12 Mile Rd, Berkley, MI 48072-1627 | |
| (248) 850-7068 | |
| (248) 850-7112 |
| Full Name | Dr Paola M Seidel |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine & Rehabilitation |
| Location | 2615 W 12 Mile Rd, Berkley, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043387749 | NPI | - | NPPES |
| 2508225182 | Other | MI | BC&BS OF MI |
| MI11611001 | Other | MI | MEDICARE ID |
| PS058096 | Other | MI | STATE LICENSE NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | PS058096 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Paola M Seidel, MD 2615 W 12 Mile Rd, Berkley, MI 48072-1627 Ph: (248) 850-7068 | Dr Paola M Seidel, MD 2615 W 12 Mile Rd, Berkley, MI 48072-1627 Ph: (248) 850-7068 |
News Archive
Changing the hue of hospital gowns and bed sheets to match a patient's skin color could greatly enhance a physician's ability to detect cyanosis and other health-related skin color changes, according to a new study from Rensselaer Polytechnic Institute.
British pharmaceutical giant GlaxoSmithKline, announced this Thursday that its second-quarter charges related to legal cases involving the two drugs Avandia (diabetes drug) and Paxil (drug for anxiety and depression) would run up to $2.36 billion. Avandia's use and its potential risk of causing heart problems were being debated this week by an advisory panel to the US Food & Drugs Administration (FDA).
St. Jude Medical, Inc., a global medical device company, today announced that physicians from the Cedars-Sinai Heart Institute will lead the company's transcatheter aortic valve implantation (TAVI) clinical trial. The study will evaluate the safety and efficacy of the St. Jude Medical transcatheter aortic valve for patients who experience severe aortic stenosis and who may be at an elevated risk for open-heart surgery.
Poor communication of the outcomes of medical tests whose results are pending at the time of a patient's hospital discharge is common and can lead to serious medical errors in post-hospitalization medical treatment.
Illumina, Inc. announced today that District Judge Sue L. Robinson of the U.S. District Court for the District of Delaware granted Illumina's motion for summary judgment of invalidity of U.S. Patent No. 7,593,109, a patent asserted by Helicos BioSciences Corporation in a lawsuit filed against Illumina in October 2010. Judge Robinson ruled that the '109 patent was invalid for inadequate written description.
› Verified 6 days ago
Dr. Matthew Jones, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2327 Phillips Ave, Berkley, MI 48072 Phone: 513-600-0959 |